HIV Treatment-Readiness Measure (HTRM) Validation
- Conditions
- HIV Infections
- Registration Number
- NCT00686049
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Brief Summary
The goal of this study is to assess the reliability of the HIV
Treatment Readiness Measure (HTRM) to assist clinicians in:
(1) determining whether or not youth living with HIV are ready to initiate HAART and (2) identifying youth who may be in need of additional support services to facilitate their adherence to HAART. The current study will examine the psychometric properties of the HTRM and establish its test-retest reliability over a two week period. If the HTRM is found to be reliable, a subsequent study will examine its predictive validity.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
- HIV-positive youth, 13 years 0 days to 24 years 364 days of age
- Either HAART naïve (defined as never having taken HAART) or HAART experienced (defined as having had at least one experience taking HAART and not having taken HAART for 30 days prior to study entry)
- Not currently on HAART, but planning to initiate HAART within the next 2 months based on provider recommendation
- Enrolled in care at an AMTU or a collaborating site
- Able to speak and understand English
- Willing to provide informed consent, or assent with parental permission (if required by the site IRB) for participation in this study.
- Evidence of cognitive impairment or other mental condition that limits his/her ability to complete the assessment (per PI or designee discretion)
- Determined by the PI (or designee) to be under the influence of psychoactive agents or intoxicated at the time of assessment to a degree that would interfere with successful completion of the questionnaire
- Visibly distraught or unstable
- Any clinical condition that would likely interfere with the participant's ability to complete the study
Participants who are unable to speak English will be excluded from the initial testing of the HTRM's reliability and validity in keeping with traditional tool development strategies. If the initial study indicates that the English version of the HTRM is reliable and valid, appropriate methods will be employed to translate the instrument into Spanish and the reliability and validity will be re-examined for the Spanish version.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To examine the factor structure and estimate the internal consistency of each factor of the HTRM. 1 year To estimate the test-retest reliability of the HTRM. Entry, Week 2
- Secondary Outcome Measures
Name Time Method To determine an appropriate system for scoring the HTRM. 1 year To examine the acceptability of the HTRM. Entry, Week 2
Trial Locations
- Locations (15)
Ruth M Rothstein CORE Center/ John H Stroger Jr Hospital
🇺🇸Chicago, Illinois, United States
Childrens Hospital of Los Angeles
🇺🇸Los Angeles, California, United States
University of California San Francisco
🇺🇸San Francisco, California, United States
Childrens Diagnostic & Treatment Center, Inc
🇺🇸Fort Lauderdale, Florida, United States
University of Miami School of Medicine
🇺🇸Miami, Florida, United States
USF College of Medicine
🇺🇸Tampa, Florida, United States
Childrens Memorial Hospital
🇺🇸Chicago, Illinois, United States
University of Maryland Express Mailing Address:
🇺🇸Baltimore, Maryland, United States
Mount Sinai Medical Center
🇺🇸New York, New York, United States
The Childrens Hospital of Philadelphia
🇺🇸Philadelphia, Pennsylvania, United States
St Jude Childrens Research Hospital
🇺🇸Memphis, Tennessee, United States
University of Puerto Rico, Medical Sciences Campus
🇵🇷San Juan, Puerto Rico
Childrens National Medical Center
🇺🇸Washington, District of Columbia, United States
Tulane University Health Sciences Center
🇺🇸New Orleans, Louisiana, United States
Montefiore Medical Center
🇺🇸Bronx, New York, United States